Publications by authors named "Nicholas Rebold"

Claim this Profile
R
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort Study.
Kaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, Nikki Tran, Taryn A Eubank

Open Forum Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors and Disparities Influencing Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide 1 Receptor Agonists Initiation in the United States: A Scoping Review of Evidence.
Josiah Moore, Ndidi Iheme, Nicholas S Rebold, Harriet Kusi, Constance Mere

Pharmacy (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM.
Dana J Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor

Pharmacotherapy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study.
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi

Infect Dis Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction.
Kaylee E Caniff, Nicholas Rebold, Michael J Rybak

Pharmacotherapy· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production.
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold

Open Forum Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam.
Sara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, Musa Mubarez, Wesley D Kufel, Nicholas Rebold

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Carbapenem-Resistant Clinical Treatment Failure.
Nicholas Rebold, Abdalhamid M Lagnf, Sara Alosaimy, Dana J Holger, Paige Witucki

Microbiol Spectr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections.
Dana J Holger, Nicholas S Rebold, Sara Alosaimy, Taylor Morrisette, Abdalhamid Lagnf

Infect Dis Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Panacea or oversimplification: Relating AUC and troughs.
Nicholas Rebold, Thomas Lodise, Michael J Rybak

Am J Health Syst Pharm· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19.
Nicholas Rebold, Sara Alosaimy, Taylor Morrisette, Dana Holger, Abdalhamid M Lagnf

Infect Dis Ther· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa.
Ashlan J Kunz Coyne, Amer El Ghali, Dana Holger, Nicholas Rebold, Michael J Rybak

Infect Dis Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections.
Nicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger

Open Forum Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant Bacteremia: STAPH Study.
Sara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, Sarah C J Jorgensen, Trang D Trinh, Nicholas Rebold

Open Forum Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options.
Nicholas Rebold, Dana Holger, Sara Alosaimy, Taylor Morrisette, Michael Rybak

Infect Dis Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis